Tower Research Capital LLC TRC Cuts Stake in Afya Limited (NASDAQ:AFYA)

Tower Research Capital LLC TRC lowered its stake in shares of Afya Limited (NASDAQ:AFYA) by 29.8% in the fourth quarter, Holdings Channel reports. The firm owned 2,306 shares of the company’s stock after selling 979 shares during the period. Tower Research Capital LLC TRC’s holdings in Afya were worth $51,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of AFYA. Renaissance Group LLC grew its stake in Afya by 6.1% during the 4th quarter. Renaissance Group LLC now owns 149,137 shares of the company’s stock valued at $3,271,000 after acquiring an additional 8,524 shares in the last quarter. Itau Unibanco Holding S.A. grew its stake in Afya by 1,004.5% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 144,264 shares of the company’s stock valued at $2,279,000 after acquiring an additional 131,202 shares in the last quarter. Mirabella Financial Services LLP purchased a new stake in Afya during the 3rd quarter valued at about $1,686,000. Campbell & CO Investment Adviser LLC grew its stake in Afya by 56.6% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 28,608 shares of the company’s stock valued at $627,000 after acquiring an additional 10,337 shares in the last quarter. Finally, Raymond James & Associates grew its stake in Afya by 134.4% during the 4th quarter. Raymond James & Associates now owns 27,695 shares of the company’s stock valued at $607,000 after acquiring an additional 15,878 shares in the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Trading Down 3.9 %

NASDAQ:AFYA traded down $0.69 on Tuesday, hitting $17.23. The stock had a trading volume of 96,918 shares, compared to its average volume of 125,644. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.45. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of 20.03, a PEG ratio of 0.57 and a beta of 0.97. The company has a fifty day moving average price of $18.99 and a two-hundred day moving average price of $19.46. Afya Limited has a 1-year low of $10.72 and a 1-year high of $22.48.

Afya (NASDAQ:AFYA) last posted its earnings results on Thursday, March 14th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.02. The company had revenue of $147.35 million for the quarter, compared to analyst estimates of $141.83 million. Afya had a net margin of 13.54% and a return on equity of 15.88%. Equities research analysts expect that Afya Limited will post 1.54 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AFYA has been the subject of several research reports. Citigroup initiated coverage on shares of Afya in a research note on Monday, January 29th. They set a “neutral” rating and a $23.00 price objective for the company. Morgan Stanley lowered shares of Afya from an “overweight” rating to an “equal weight” rating and boosted their target price for the company from $20.50 to $23.00 in a report on Monday, January 22nd.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.